Cargando…

A Case of Anti-Leucine-Rich Glioma-Inactivated Protein 1 (Anti-LGI1) Encephalitis With an Unusual Frontomesial Motor Cortex T2 MRI Hyperintensity

Anti-leucine-rich glioma-inactivated protein 1 (anti-LGI1) encephalitis is a rare autoimmune disorder, classified within limbic encephalitides, and characterized by seizures and subacute cognitive-behavioral impairment, mainly affecting short-term memory and usually involving temporo-mesial lobe str...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papiri, Giulio, Puca, Emanuele, Marcucci, Matteo, Paci, Cristina, Cagnetti, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674110/ https://www.ncbi.nlm.nih.gov/pubmed/36415395 http://dx.doi.org/10.7759/cureus.30480

Ejemplares similares

Anti-Leucine-Rich Glioma-Inactivated 1 (Anti-LGI 1) Limbic Encephalitis and New-Onset Psychosis: A Case Report
por: Alho, António, et al.
Publicado: (2023)

An Unusual Case of LGI1 (Leucine-Rich Glioma-Inactivated Protein 1) Limbic Encephalitis With Anti-acetylcholine Receptor and Anti-striational Autoantibodies
por: Pathak, Akash, et al.
Publicado: (2023)

Motor Phenomena Associated With Leucine-Rich Glioma-Inactivated (LGI1) Emi-Encephalitis
por: Giorelli, Maurizio, et al.
Publicado: (2023)

Psychiatric Manifestation of Anti-LGI1 Encephalitis
por: Endres, Dominique, et al.
Publicado: (2020)

Positive LGI1 Antibodies in CSF and Relapse Relate to Worse Outcome in Anti-LGI1 Encephalitis
por: Cui, Li-li, et al.
Publicado: (2021)

Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations
por: Lee, Jung-Ju, et al.
Publicado: (2013)

Anti-LGI1 encephalitis with initiating symptom of seizures in children
por: Wang, Yang, et al.
Publicado: (2023)

Risk Factors for Mortality in Anti-NMDAR, Anti-LGI1, and Anti-GABABR Encephalitis
por: Zhong, Rui, et al.
Publicado: (2022)

A Patient with Limbic Encephalitis Associated with Anti-leucine-rich Glioma-inactivated 1 (LGI1) Antibody Presenting with Slowly Progressive Cognitive Impairment and Fluctuating Striatal Lesions
por: Sato, Mitsuto, et al.
Publicado: (2018)

Comprehensive B-Cell Immune Repertoire Analysis of Anti-NMDAR Encephalitis and Anti-LGI1 Encephalitis
por: Feng, Jingjing, et al.
Publicado: (2021)

Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis
por: Muñiz-Castrillo, Sergio, et al.
Publicado: (2021)

Case Report: Anti-LGI1 Limbic Encephalitis Associated With Anti-thyroid Autoantibodies
por: Otiniano-Sifuentes, Ricardo, et al.
Publicado: (2021)

Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia
por: Yuan, Xiaoling, et al.
Publicado: (2020)

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA(B)R encephalitis
por: de Bruijn, Marienke A.A.M., et al.
Publicado: (2019)

Seizures and risk of epilepsy in anti‐NMDAR, anti‐LGI1, and anti‐GABA(B)R encephalitis
por: Shen, Chun‐Hong, et al.
Publicado: (2020)

Relapses of Anti-NMDAR, Anti-GABABR and Anti-LGI1 Encephalitis: A Retrospective Cohort Study
por: Zhong, Rui, et al.
Publicado: (2022)

Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination
por: Zlotnik, Yair, et al.
Publicado: (2022)

Anti-LGI1 Encephalitis Presented With Prominent Psychosis Without Loss of Consciousness
por: Cho, Ja Hyeon, et al.
Publicado: (2023)

Comparison of quantitative FDG-PET and MRI in anti-LGI1 autoimmune encephalitis
por: Sadaghiani, Mohammad S., et al.
Publicado: (2023)

Middle Cerebral Artery Dissection: A Report of Two Cases With Treatments and Outcomes
por: Papiri, Giulio, et al.
Publicado: (2023)

Leucine-rich glioma-inactivated protein 1 (LGI-1) mediated limbic encephalitis associated with syndrome of inappropriate antidiuretic hormone secretion: a case report
por: Whiles, Emily, et al.
Publicado: (2020)

Primary B Cell Lymphoma of the CNS Mimicking Anti-LGI1 Limbic Encephalitis
por: Thomas, Christian, et al.
Publicado: (2018)

Recognition of seizure semiology and semiquantitative FDG‐PET analysis of anti‐LGI1 encephalitis
por: Li, Tao‐Ran, et al.
Publicado: (2021)

Anti-LGI1 Encephalitis Developing Immunoglobulin Responsive Orthostatic Hypotension after Remission
por: Orimo, Kenta, et al.
Publicado: (2020)

Anti-LGI1 encephalitis following COVID-19 vaccination: a case series
por: Asioli, Gian Maria, et al.
Publicado: (2022)

The diagnosis of anti-LGI1 encephalitis varies with the type of immunodetection assay and sample examined
por: Muñoz-Sánchez, Guillermo, et al.
Publicado: (2022)

New Insights on DR and DQ Human Leukocyte Antigens in Anti-LGI1 Encephalitis
por: Segal‬‏, Yahel, et al.
Publicado: (2023)

Fire acupuncture for anti-LGI1 antibody autoimmune encephalitis: a case report
por: Liu, Yu, et al.
Publicado: (2023)

Efficacy of immunotherapy and prognosis in anti‐LGI1 encephalitis patients: A meta‐analysis
por: Kong, Xueying, et al.
Publicado: (2023)

Case report: Anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19
por: Li, Yanfei, et al.
Publicado: (2023)

Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures
por: Flanagan, Eoin P., et al.
Publicado: (2015)

Striatum Involvement in LGI1 Limbic Encephalitis
por: Plantone, Domenico
Publicado: (2018)

CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients
por: Lin, You-ting, et al.
Publicado: (2019)

Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature
por: Karvigh, Sanaz Ahmadi, et al.
Publicado: (2022)

Clinical Characteristics of Cognitive Impairment and 1-Year Outcome in Patients With Anti-LGI1 Antibody Encephalitis
por: Hang, Hai-lun, et al.
Publicado: (2020)

A rare case of anti-LGI1 limbic encephalitis with concomitant positive NMDAR antibodies
por: Ji, Tuo, et al.
Publicado: (2020)

Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis
por: Rissanen, Eero, et al.
Publicado: (2022)

Thymoma-associated anti-LGI1 encephalitis and myasthenia gravis: A unique combination with autoantibodies
por: Satake, Akane, et al.
Publicado: (2022)

Case Report: Paroxysmal hyperhidrosis as an initial symptom in a patient with anti-LGI1 encephalitis
por: Qiao, Tingting, et al.
Publicado: (2022)

Rapidly Progressive Cognitive Impairment with Faciobrachial Dystonic Seizures (FBDS) in Anti-LGI1 Encephalitis
por: Yin, Weifang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t1pt0tuvrro88ir0adue2va7vj